|
Title
|
Publication Date
|
Price
|
Relevance
|
|
Medical Imaging Markets: Contrast Agents
|
Nov 2009 |
£2,215 |
100% |
World OTC Pharmaceutical Markets
Self-Medication, Developing and Petro-Rich Economies, BTC and Other Growth Trends
|
May 2008 |
£2,025 |
99% |
Medical Imaging Markets, Volume I
Radiography (X-Ray, Digital X-Ray, Fluoroscopy, Mammography, and Ct Markets)
|
Feb 2009 |
£2,215 |
97% |
|
Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound
|
Aug 2009 |
£2,215 |
96% |
|
World Market for Medical Beds, The
|
Nov 2011 |
£1,895 |
95% |
Multiple Sclerosis Treatment
World Drug Market 2012-2022
|
Nov 2011 |
£1,699 |
94% |
|
Global Medical Imaging Equipment Market 2008-2012
|
Jun 2009 |
£710 |
94% |
|
Global Cardiovascular Device Markets 2007-2012
|
Jan 2007 |
£1,875 |
93% |
|
U.S. Alzheimer's Disease Medication Market
|
Aug 2010 |
£3,795 |
92% |
|
US Healthcare Sector Forecast to 2012
|
Dec 2010 |
£630 |
91% |
|
Women's Health Diagnostic Testing
|
Jun 2010 |
£2,150 |
91% |
Biobanking for Medicine
Technology and Market 2012-2022
|
Dec 2011 |
£1,699 |
91% |
|
Point of Care Diagnostic Testing World Markets
|
Jul 2011 |
£2,150 |
91% |
Point of Care Diagnostics:
World Market Outlook 2012-2021
|
Dec 2012 |
£1,699 |
90% |
Home Medical Equipment
US industry forecasts for 2012 & 2017
|
Jan 2009 |
£2,910 |
90% |
|
Cardiac Pacemakers
|
Apr 2008 |
£2,500 |
90% |
Biochips
Industry forecasts for 2012 & 2017
|
Oct 2008 |
£2,910 |
90% |
Private Healthcare Market in Romania 2010
Development Forecasts for 2010-2012
|
Mar 2010 |
£1,410 |
90% |
Chinese Pharmaceutical Market
2012-2022
|
Dec 2011 |
£1,699 |
90% |
|
Israel Healthcare IT Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1,895 |
90% |
|
Asian Medical Device Markets
|
May 2007 |
£2,525 |
90% |
|
Naturlose (Type 2 Diabetes) – Analysis and Forecasts to 2020
|
Oct 2011 |
£1,265 |
90% |
|
Specialty Medical Chairs
|
Oct 2008 |
£2,180 |
90% |
Moldova Pharmaceuticals and Healthcare Report Q1
2012
|
Jan 2012 |
£330 |
89% |
|
U.S. Asthma/COPD Market
|
Apr 2011 |
£3,795 |
89% |
|
Dapagliflozin (Type 2 Diabetes) – Analysis and Forecasts to 2020
|
Oct 2011 |
£1,265 |
89% |
|
Australia Healthcare IT Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1,895 |
89% |
|
Virtual Reality in Healthcare 2008-2012
|
Apr 2009 |
£710 |
89% |
GSK's Cervarix
A Future Blockbuster of 2007
|
Mar 2007 |
£1,999 |
89% |
|
Global Ophthalmic Market Analysis & Forecasts to 2012
|
Apr 2007 |
£1,499 |
88% |
